Difelikefalin

본문 바로가기


Home > Product > Difelikefalin
Selling leads
Difelikefalin
Posting date : Jun 27, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

​Dafililin is a novel drug discovered by CaraTherapeutics and developed by ViforPharma. It was approved by the USFDA and the European Medicines Agency (EMA) in 2021 for the treatment of moderate to severe pruritus. It is a highly selective κ -opioid receptor agonist, administered by intravenous injection. The purpose of the illegal forest is to limit its effect on the peripheral nervous system, thereby reducing the side effects of the central nervous system, such as sedation, anxiety and hallucinations. This peripheral limitation gives difelikefalin a potential advantage in treating pruritus, especially among patients who experience refractory pruritus due to renal failure or other diseases.​


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top